Patents Assigned to IMMUNIS.AI, INC.
  • Methods of detecting prostate cancer
    Patent number: 12181477
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer
    Type: Grant
    Filed: February 20, 2023
    Date of Patent: December 31, 2024
    Assignee: IMMUNIS.AI, INC.
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno
  • Methods of detecting cancer
    Patent number: 12037645
    Abstract: This invention provides a set of biological markers that are useful for detecting cancer. This invention further provides methods of using those biological markers for the diagnosis, prognosis, or monitoring of cancer.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: July 16, 2024
    Assignee: IMMUNIS.AI, INC.
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wonjo
  • Methods of detecting prostate cancer
    Patent number: 11585814
    Abstract: The invention described herein provides biological markers for the diagnosis, prognosis, and monitoring of prostate cancer.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: February 21, 2023
    Assignee: IMMUNIS.AI, INC.
    Inventors: Amin I. Kassis, Harry Stylli, Colleen Kelly, Geoffrey Erickson, Kirk J. Wojno